Anti-OX40 antibody
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Anti-OX40 antibody, covering 2014-04-01 to 2014-04-01. Get the full timeline:
Most recent: Clinical Trial Update: Study of the Combination of Anti-OX40 and Ipilimumab in Patients With Metastatic Melanoma [Phase 1, Phase 2]